Laboratory Medicine ›› 2019, Vol. 34 ›› Issue (7): 633-636.DOI: 10.3969/j.issn.1673-8640.2019.07.014

• 技术研究与评价·论著 • Previous Articles     Next Articles

Role of multiplexed bead-based immunoassay in the determination of AAV

ZHANG Cheng, YANG Ying, WU Shanshan, LÜ Dan, ZHANG Tingting   

  1. Department of Clinical Laboratory,the Affiliated Hospital of Liaoning University of Traditional Chinese Medicine,Shenyang 110032,Liaoning,China
  • Received:2019-01-16 Online:2019-07-30 Published:2019-07-25

Abstract:

Objective To investigate the role of multiplexed bead-based immunoassay in the determination of anti-neutrophil cytoplasmic antibody(ANCA)-associated vasculitis(AAV). Methods A total of 300 patients with AAV,275 autoimmune disease patients without AAV and 277 healthy subjects(healthy control group) were enrolled. The roles of indirect immunofluorescence assay(IFA),line immunoassay(LIA) and multiplexed bead-based immunoassay were evaluated by comparing the results of ANCA,anti-myeloperoxidase(MPO) antibody and anti-protease 3(PR3) antibody determinations. The optimal method for the determination of AAV was screened. Results There was no difference in the positive rate between LIA and multiplexed bead-based immunoassay by comparing the results of anti-MPO antibody and anti-PR3 antibody determinations. The positive rates were 83.1% and 78.2%,respectively,and the kappa value was >0.75. Multiplexed bead-based immunoassay showed higher sensitivity and specificity(85.7% and 82.6%) than those of LIA(59.7% and 56.6%)(P<0.05). The models of cytoplasmic antineutrophil cytoplasmic antibody(cANCA)+PR3 and perinuclear antineutrophil cytoplasmic antibody(pANCA)+MPO showed higher positive rates in the diagnosis of AAV,and the positive rates were 42.4% and 45.0%,respectively. Conclusions Multiplexed bead-based immunoassay shows high sensitivity and specificity for ANCA determination,and the combined determination with IFA plays a role in the diagnosis of AAV.

Key words: Multiplexed bead-based immunoassay, Anti-neutrophil cytoplasmic antibody-associated vasculitis, Line immunoassay, Indirect immunofluorescence assay

CLC Number: